AXOVANT GENE THERAPIES LTD. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • January 10th, 2020 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 10th, 2020 Company Industry JurisdictionDEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between AXOVANT GENE THERAPIES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
AXOVANT GENE THERAPIES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OFCommon Share Warrant Agreement • January 10th, 2020 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 10th, 2020 Company Industry JurisdictionCOMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between AXOVANT GENE THERAPIES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
AXOVANT GENE THERAPIES LTD. and , AS WARRANT AGENT FORM OF PREFERENCE SHARE WARRANT AGREEMENT DATED AS OFPreference Share Warrant Agreement • January 10th, 2020 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 10th, 2020 Company Industry JurisdictionPREFERENCE SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between AXOVANT GENE THERAPIES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).